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There is a need to optimize storage conditions to preserve cell characteristics during transport of cultured cell sheets from
specialized culture units to distant hospitals. In this study, we aimed to explore a method to identify additives that diminish the
decrease in the viability of stored undifferentiated epidermal cells using multifactorial design and an automated screening
procedure. The cultured cells were stored for 7–11 days at 12°C in media supplemented with various additives. Effects were
evaluated by calcein staining of live cells as well as morphology. Twenty-six additives were tested using (1) a two-level factorial
design in which 10 additives were added or omitted in 64 different combinations and (2) a mixture design with 5 additives at 5
different concentrations in a total of 64 different mixtures. Automated microscopy and cell counting with Fiji enabled efficient
processing of data. Significant regression models were identified by Design-Expert software. A calculated maximum increase of
live cells to 37± 6% was achieved upon storage of cell sheets for 11 days in the presence of 6% glycerol. The beneficial effect of
glycerol was shown for epidermal cell sheets from three different donors in two different storage media and with two different
factorial designs. We have thus developed a high throughput screening system enabling robust assessment of live cells and
identified glycerol as a beneficial additive that has a positive effect on epidermal cell sheet upon storage at 12°C. We believe this
method could be of use in other cell culture optimization strategies where a large number of conditions are compared for their
effect on cell viability or other quantifiable dependent variables.
1. Introduction
The first example of regenerative medicine occurred in 1984
with life-saving transplantation of cultured epidermal cells
sheets (CES) to two boys with severe large area burns [1].
CES continues to be commonly used in clinics to regenerate
skin in cases of large area burns and chronic hard-to-heal
ulcers [2]. They also have potential for use as an autologous
epithelial cell layer, which can be substituted to regenerate
other types of epithelia in the body. Examples include use
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of CES in regeneration of damaged cornea [3] and urethra [4]
in animal models. It is expected that transplantation of a high
percentage of viable cells in the CES is important to ensure
successful integration following transplantation.
The demand for CES may increase as the field of regener-
ative medicine becomes more established. However, the need
for increased safety regulations means that culture facilities
are becoming progressively centralized to meet strict require-
ments [5]. This opens up a gap between patients at regional
centers and specialized culture facilities. In the present study,
we aimed to develop a system for storage and transport that
would make high quality CES available for an extended
period of time. This would allow expanded delivery to clinics
regionally and internationally [6]. In addition, short-term
storage accommodates patient needs in cases of critical life-
threatening large area burns. It allows a larger window for
use of large batches of autologous CES where successive
surgeries are necessary. It also gives flexibility in the timing
of surgery depending on the status of the patient. In addition,
the flexibility provided by optimal storage conditions could
lead to more efficient use of hospital resources during prepa-
ration of CES and when scheduling surgery time. A stable
storage period provides the further benefit of a window for
extensive quality control testing [7].
Earlier studies have shown that storage of CES at 12°C is
optimal for preserving undifferentiated epidermal cell char-
acteristics and provides close to 100% viability over a one-
week storage period [8, 9]. However, viability falls to ~60%
over a two-week storage period [9, 10]. Identification of one
or more additives that significantly improve cell viability
and morphology could extend storage time beyond one week
and improve the quality of CES delivered for surgery. To test
a large number of additives, we chose a factorial design
approach over one-factor-at-a-time testing making use of a
software package, Design-Expert® developed by Stat-Ease
Inc. This reduced the number of experiments necessary to
test all possible interactions between the selected test addi-
tives. The design of experiment approach also allowed auto-
mation of data analysis to a large degree, thus further
improving accuracy and efficiency.
2. Materials and Methods
2.1. Overview of Strategy. Additives were selected for testing
based on a literature search for substances shown to combat
oxidative damage and/or increase cell proliferation. Relevant
additives were first tested as a two-level multiple combina-
tion, in which sets of 10 different additives (Tables 1 and 2)
Table 1: Tested additives and suppliers.
Additive Concentration Supplier
Acetovanillone 50 μM Sigma-Aldrich (St. Louis, MO)
Adenosine 5mM Sigma-Aldrich (St. Louis, MO)
Allopurinol 1mM Sigma-Aldrich (St. Louis, MO)
Antimycin A 20 nM Sigma-Aldrich (St. Louis, MO)
Aspirin (acetylsalicylic acid) 133–400 μg/ml Sigma-Aldrich (St. Louis, MO)
ATP (adenosine triphosphate) 67–200 μM Sigma-Aldrich (St. Louis, MO)
Dimethyl (S)-(−)-malate 2,5mM Sigma-Aldrich (St. Louis, MO)
DMSO (dimethyl sulfoxide) 0.07–0.20% Sigma-Aldrich (St. Louis, MO)
Fenoldopam mesylate 6.7–20 μM Sigma-Aldrich (St. Louis, MO)
L-Gluthatione 3mM Sigma-Aldrich (St. Louis, MO)
Glycerol 7.5–100mg/ml Sigma-Aldrich (St. Louis, MO)
Hydrocortizone 3 ng/ml Sigma-Aldrich (St. Louis, MO)
Icilin 0.33–1 μM Santa Cruz Biotechnology (Heidelberg, Germany)
Insulin 5 μg/ml Sigma-Aldrich (St. Louis, MO)
Lactic acid 13–40mM Sigma-Aldrich (St. Louis, MO)
L-Ascorbic acid 50 μg/ml Sigma-Aldrich (St. Louis, MO)
L-carnosine 13.3–40mM Sigma-Aldrich (St. Louis, MO)
Leukemia inhibitory factor (LIF) 13–40 ng/ml Sigma-Aldrich (St. Louis, MO)
LiCl 1mM Merck (Oslo, Norway)
Melatonin 0.67–2 nM Calbiochem (San Diego, CA)
Menthol 16.7–50 μM Santa Cruz Biotechnology (Heidelberg, Germany).
Methyl pyruvate 1mM Sigma-Aldrich (St. Louis, MO)
N-(2-Mercaptopropionyl)glycine (NMPG) 100 μM Sigma-Aldrich (St. Louis, MO)
N-Acetyl-L-cysteine 1mM Sigma-Aldrich (St. Louis, MO)
Sodium pyruvate 10mM Sigma-Aldrich (St. Louis, MO)
Taurine 20mM Sigma-Aldrich (St. Louis, MO)
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were evaluated in experiments 1 and 2 for combinatorial
effects, using epidermal cells from two different donors,
respectively. Cultured confluent CES were stored for 7 days
at 12°C in experiments 1 and 2. The following experiments,
3 and 4 used a mixture design, testing storage for 11 days
using 5 additives at 5 levels with epidermal cells from two dif-
ferent donors, respectively. Glycerol, the best candidate from
experiment 1, was carried forward for further verification in
all experiments.
2.2. Supplies. Medium for epidermal cells (CnT-Prime) was
purchased from CELLnTEC (Bern, Switzerland). Trypsin-
EDTA, glycerol, 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid (HEPES), and NaHCO3 were purchased from
Sigma-Aldrich (St. Louis, MO). Nunclon Δ surface mul-
tidishes, pipettes, and other routine plastics were obtained
from VWR International (West Chester, PA). Phosphate-
buffered saline (PBS) and Minimum Essential Medium
(MEM) were from Life Technologies (Carlsbad, CA). Icilin
and menthol were from Santa Cruz Biotechnology (Heidel-
berg, Germany). Suppliers for tested additives are presented
in Table 1. Storage Mat III for 96 Well Plates (Corning,
NY) were used for air-tight covering of microtiter plates at
storage. Live and dead cells were assessed by the LIVE/
DEAD® Viability/Cytotoxity Kit (molecular probes, OR).
2.3. Cell Culture. Human tissue was used in accordance with
the Declaration of Helsinki and was harvested from adult
female donors undergoing breast reduction or abdominal
reduction surgery (abdominoplasty) following written
informed consent. Local ethical committee approval was
obtained for the use of tissue from the Department of Plastic
Surgery, Oslo University Hospital, Oslo, Norway [2013/815/
REK]. Cells were obtained as described [8], seeded (6000
cells/well) in serum-free CnT-Prime medium on Collagen
IV coated 96-well Nunclon Δ surface multidishes, and
Table 2: Summary of experiments.
Exp. # Design type Donor/source Storage time Tested additives
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cultured in a 5% CO2 incubator at 37
°C for 5–7 days to obtain
a confluent monolayer. Culture medium was changed every
two days.
2.4. Use of Factorial Design to Evaluate Optimal
Concentrations and Combinations of Additives. Various
additives were evaluated by one or both of the design types
(210 or 55) as specified in Table 2 and explained below.
Design type 210 was used in experiments 1A, 1B, and 2. It
comprised a setup with 10 different additives, each at two
levels for evaluation of combinatorial effects. Design-
Expert® software enabled a 64-run (64 individual mixtures),
fractional factorial single-plate design. Thus, all combina-
tions of 10 additives at a time could be evaluated while reduc-
ing the number of a full factorial experiment (210 = 1024
possible combinations) to 64. This experiment setup is
shown in Table S1. Design type 55 was used in experiments
3 and 4. It was comprised of a mixture factorial design, in
which 5 additives at 5 different combinations were evaluated
by response surface methodology [11] and a central compos-
ite design [12]. While a full factorial experiment would need
55= 3125 experimental groups, we could design a single plate
setup with 64 runs (mixtures) with the aid of the Design-
Expert® software. This design setup is presented in Table S2.
2.5. Cell Storage. Cells were stored with various combinations
of additives for seven or eleven days before assessment of the
additives’ effect on viability and morphology. A Biomek 4000
automated workstation (robot) was used to mix concentrated
solutions of additives or MEM storage medium (MEM with
25mM HEPES, 300mg/l NaHCO3, and 50μg/ml gentamy-
cin) into 64 wells of a 96-well reservoir plate. From the reser-
voir plate, the storage media containing various additives
were distributed into 64 wells of 96-well plates (n = 6) that
contained confluent epidermal cells to be stored. Each well
was made air tight by covering with Storage Mat III™ and
the plates were stored at 12°C for 7 or 11 days. The standard
deviation of the temperature in each storage container was
±0.4°C as demonstrated previously [13]. Following storage,
the medium was replaced with CnT-Prime medium, and cells
were allowed to equilibrate at 37°C and 5% CO2 for 3 h before
further analysis in order to include assessment of any poten-
tial damage incurred upon rewarming [9].
2.6. Quantitative Analysis of Live and Dead Cells. After equil-
ibration of stored cells for 3 hours at 37°C in growth medium,
live and dead cells were stained with calcein or ethidium,
respectively, using a LIVE/DEAD® kit according to the man-
ufacturer’s instructions. After staining, photomicrographs of
the cultures were captured using a Nikon Eclipse Ti fluores-
cence microscope with a DS-Qi1 black-and-white camera
and a motorized stage. Photographs were taken automati-
cally using the “capture multipoint” function and autofocus-
ing with “steps in range.” The exposure length and gain was
maintained at a constant level for all samples, and the fluo-
rescence intensities of the fluorochromes were within the
dynamic range of the camera. The number of live or dead
cells per square unit (picture) was automatically quantified
using Fiji (National Institutes of Health, Bethesda, MD,
USA) [14]. See supplementary for script and details. The
numbers were further analyzed by the Design-Expert® soft-
ware (Stat-Ease Inc., Minneapolis, MN) as described below.
Measurements of dead cells gave conflicting results,
which is likely due to the fact that only attached dead cells
can be counted. Thus, a significant part of dead cells could
not be counted since the cell layer had disrupted and cells
had detached from the plate.
2.7. Assessment of Morphology. The morphology of stored
cells was evaluated based on pictures from each run. The cells
were given marks between 1 and 4 based on subjective evalu-
ation of cell integrity, confluence, density, and shape and
were evaluated blindly by two persons. Average marks from
up to 6 parallel plates were subjected to analysis by Design-
Expert® software as described below.
2.8. Statistical Methods. Various regression models (linear,
quadratic, reduced quadratic, special cubic, and cubic) were
tested with the aid of Design-Expert® software to best
describe the results, and recommended models were selected
based on highest significance. In experiment 1, a sum of
squares model was selected as the best fit for viability data,
while a quadratic model was best fit to data on morphology.
For the remaining experiments, a reduced quadratic model
showed the best fit. The theory behind mixture design and
analysis is described by Cornell [15]. In short, the measured
response (e.g., number of live cells after storage) depends
on the proportion of each ingredient (additive) in the mix-
ture and not the amount of mixture. The blending of addi-
tives, each at multiple proportions of the mixture in
different runs/mixtures, allows prediction of favorable/unfa-
vorable individual additives as well as calculation of synergis-
tic or antagonistic effects between different additives.
Significant effects of the various additives were tested within
the Design-Expert® software using analysis of variance
(ANOVA). Pearson correlation was used to test relative
effects of additives in two different storage media, and Stu-
dent’s t-test was used to evaluate the difference in number
of live cells after storage in the two media.
3. Results
3.1. Experiment 1. In experiment 1, effects of 10 additives
were compared in two different basic storage media, CnT
Prime (experiment 1A) and Minimum Essential Medium
(MEM) (experiment 1B), previously shown to be beneficial
for storage experiments [16, 17]. Relative effect of additives
were similar across the 64 tested combinations between the
two storage media (r = 0 72), but storage in MEM resulted
in 30.5% more live cells after storage (p value: 1.0× 10−12)
as compared to CnT Prime. Thus, MEMwas used as the stor-
age medium in all following experiments.
3.1.1. Live Cells.Using the sum of squares model, cell viability
results (Table 3) showed that glycerol, adenosine, and
antimycin-A alone, as well as the combination of glycerol
and l-ascorbic acid, had a significant effect on the number
of viable cells. Figure 1(a) shows the relative magnitude and
direction of effect. Adenosine and antimycin-A had a
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significant negative effect on cell survival (p < 0 0001 and p
= 0 0010, respectively). Glycerol had a significant positive
effect on cell survival that was maintained after Bonferroni
correction for multiple testing (p = 0 0002) [18]. Glycerol
combined with L-ascorbic acid showed significant positive
effects (p = 0 0022) but did not sustain Bonferroni correction
for multiple testing. Simulation by the Point Prediction tool
in Design-Expert (Table S3) indicated that 1% glycerol in
MEM would increase the number of live cells by 1.8% com-
pared to MEM basic storage medium without additives.
The predicted increase in live cells with the combination of
glycerol and L-ascorbic acid was 8.0%. It should be noted that
none of the combinations tested in Experiment 1 included
just MEM+glycerol or MEM+glycerol + L-ascorbic acid;
thus, these are calculated effects.
3.1.2. Morphology. The quadratic model predicted that
glycerol was the single additive that resulted in better
morphology compared to MEM basic storage medium alone
(p = 0 0049, data not shown). However, the effect did not
sustain adjustment for multiple testing by the Bonferroni
method (Figure 1(b)). As found for analysis of live cells,
adenosine and antimycin A showedmarkedly negative effects
on cell morphology.
3.2. Experiment 2. For experiment 2, eight more additives
were tested in addition to glycerol at 0.75% and 3% using
epidermal cells from a different donor (Tables 1 and 2).
No significant effects on live or dead cells or morphology
were detected.
3.3. Experiment 3. For experiment 3, a mixture design with 5
additives at 5 different concentrations was used. This experi-
ment was designed to identify the optimal concentration of
glycerol in combination with 4 other candidate additives
during storage for 11 days (Tables 1 and 2). Glycerol was
included in some of the mixtures at varying concentrations
from 2.0 to 6.0%.
3.3.1. Live Cells. The reduced quadratic mixture model
predicted that glycerol, fenoldopam mesylate, carnosine,
and DMSO added as single additives significantly affected
the number of live cells (Table 4). Using the Point Prediction
tool, the maximum concentration of glycerol (6%) was
calculated to result in a 35% increase in viable cells
(Table 5). Fenoldopam mesylate as a single additive gave a
predicted result of a 5% increase in the number of viable cells
at its optimal concentration (11μM). Glycerol in combina-
tion with fenoldopam mesylate was also significantly
positively associated with an increased number of live cells
after 11 days of storage. The maximum number of live cells
was predicted at 6% glycerol +8μM fenoldopam mesylate,
with an increase in cell viability of 37% (Table 5). Carnosine
worked against the positive effect of glycerol, while DMSO




















































Figure 1: Charts displaying the relative effects of the various additives on number of live cells (a) or morphology (b). The y-axis shows t values
of the absolute effects on the cells upon addition of various additives (x-axis). Blue or red bars: additives calculated to have negative or positive
effects, respectively, on the number of live cells compared to storage without any additive. Filled bars = significance> 0.05 (not significant)
No-fill bars = significance< 0.05 (significant). The figures are reconstructed in Prism Graph Pad from output in Design-Expert to improve
clarity.
Table 3: Effect of different additives on the number of live cells after one-week storage.
Additives F value p value prob > F Effect
Adenosine (5mM) 42.31 <0.0001 −
L-Ascorbic acid (50 μg/ml) 0.20 0.6575
Glycerol (1%) 16.19 0.0002 +
Antimycin A (20 nM) 12.09 0.0010 −
L-Ascorbic acid and Glycerol (50 ug/ml and 1%, respectively) 10.25 0.0022 +
F value: test for comparing model variance with residual variance; p value prob > F: probability of observed F value if the null hypothesis is true (small value call
for rejection of the null hypothesis). Only additives involved in a significant or positive effect on viability are shown. Parentheses indicate tested concentrations
of the respective additives. All additives were added to MEM basic storage medium.
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3.3.2. Morphology. The reduced quadratic mixture model
predicted that carnosine and fenoldopam mesylate, sepa-
rately and together, had a beneficial effect on morphology
(Table 6). In line with the effect on the number of live cells,
glycerol in combination with fenoldopam mesylate had a
positive effect on morphology, while glycerol in combination
with carnosine showed a negative effect. LIF and DMSO
abolished the positive effect of fenoldopam mesylate, while
carnosine showed a positive effect on morphology with LIF
but negative with DMSO.
3.4. Experiment 4. For experiment 4, we used the same exper-
imental design as in experiment 3 (a mixture design with 5
additives at 5 different concentrations) with cells from the
same donor as used in experiment 2 but at a later passage
(P3). Cell sheets were stored for 11 days. Glycerol was
included in some of the mixtures at varying concentrations
from 3.3 to 10.0%.
3.4.1. Viability.A reduced quadratic mixture model was the
best fit for the cell viability data (p < 0 0001), and analysis
of the 5 substances as single additives indicated that only
glycerol had a positive effect (p = 0 0004, Table 7). Glyc-
erol in combination with any of the other 4 additives
had a significant negative effect. Simulation by the Point
Prediction tool in experiment 4 indicated that the
theoretical optimal concentration of glycerol as a single
additive was 3.6%, at which the number of live cells was
predicted to increase by 7.1% (Table 8).
3.4.2. Morphology. The only single additives predicted to
result in a significant positive effect on morphology in exper-
iment 4 were carnosine and fenoldopam mesylate. Glycerol
as a single additive did not reach significance but had a
Table 4: Reduced quadratic mixture model for the number of live
cells.
Additives F value p value prob > F Effect
Carnosine (40mM) 5.66 0.0213 +
DMSO (0.2%) 10.88 0.0018 −
Fenoldopam mesylate (10 μM) 6.79 0.0121 +
Glycerol (6%) 5.11 0.0283 +
Carnosine +DMSO (0.2%) 15.78 0.0002 −
Carnosine + glycerol 27.15 <0.0001 −
Carnosine + LIF (40 ng/ml) 3.27 0.0768
DMSO+ glycerol 4.55 0.0380 −/+
Fenoldopam mesylate + LIF 3.11 0.0839
F value: test for comparing model variance with residual variance; p value
prob > F: probability of observed F value if the null hypothesis is true
(small value call for rejection of the null hypothesis). Parentheses indicate
maximal tested concentrations of the relevant additives and not necessarily
the optimal levels.
Table 5: Estimated number of live cells by the Design-Expert Point
Prediction tool.
Mean Std dev 95% CI low 95% CI high
Predicted number of live cells with no additives
1814 149 1665 1963
Predicted number of live cells at 6.0% glycerol
2420 149 2232 2608
Predicted number of live cells at 6% glycerol + 8uM fenoldopam
mesylate
2461 149 2312 2609





p value prob > F Effect
Carnosine (40mM) 9.31 0.0037 +
Fenoldopam mesylate (10 μM) 48.90 <0.0001 +




Carnosine + glycerol (6%) 9.20 0.0039 −
Carnosine + LIF (40 ng/ml) 8.19 0.0062 +
DMSO+ fenoldopam mesylate 69.17 <0.0001 −
Fenoldopam mesylate + glycerol 64.85 <0.0001 +
Fenoldopam mesylate + LIF 25.24 <0.0001 −
F value: test for comparing model variance with residual variance; p value
prob > F: probability of observed F value if the null hypothesis is true
(small value call for rejection of the null hypothesis) Parentheses indicate
maximal tested concentrations of the relevant additives and not necessarily
the optimal levels.
Table 7: Reduced quadratic mixture model for the number of live
cells.
Additives F value p value prob > F Effect
Glycerol (10%) 14.41 0.0004 +
Lactic acid 2.87 0.0964 −
Glycerol + aspirin (400 μg/ml) 5.89 0.0187 −
Glycerol +ATP (200 μM) 12.34 0.0009 −
Glycerol + lactic acid (40mM) 15.78 0.0002 −
Glycerol +melatonin (2 nM) 8.72 0.0047 −
F value: test for comparing model variance with residual variance; p value
prob > F: probability of observed F value if the null hypothesis is true
(small value call for rejection of the null hypothesis) Parentheses indicate
maximal tested concentrations of the relevant additives and not necessarily
the optimal levels.
Table 8: Predicted number of live cells using the Design-Expert
Point Prediction tool.
Mean Std dev 95% CI low 95% CI high
Predicted number of live cells with no additives
924 139 796 1053
Predicted number of live cells at 3.8% glycerol
990 139 875 1105
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positive effect in combination with fenoldopam mesylate.
Combinations of carnosine with fenoldopam mesylate or
LIF were also calculated to have a positive effect on morphol-
ogy. Carnosine + glycerol had a negative effect on morphol-
ogy, while the combination of carnosine with DMSO had a
positive effect on morphology. Using the Point Prediction
tool for morphology data, the maximal predicted number
of live cells was achieved at 18.4mM carnosine+ 15 uM
fenoldopam mesylate + 6% glycerol + 40ng/ml LIF, increas-
ing the morphology ranking by 52%. Figure 2 shows an
example of cells prior to storage as well as high and low mor-
phology ranked wells after 11 days of storage. Cells with high
morphology rating look very similar to nonstored cells.
4. Discussion
We have successfully developed a high throughput method
for screening the individual and combined effect of media
additives on CES during storage. We tested various combina-
tions and concentrations of additives for their effect on
survival and morphology of undifferentiated epidermal cells
during storage at 12°C. In this study, we used two different
multifactorial designs based on Design-Expert® software.
Accurate, high throughput analysis was enabled by auto-
mated photography of calcein-stained cells followed by auto-
mated cell counting using the Multiple Image Processor
function within Fiji [14]. Visual evaluation of morphology
was also performed. A limited number of studies have used
multifactorial design to screen for various cell traits; exam-
ples include Jakobsen et al., who analyzed combinations of
5 different factors in a full 25 factorial design for optimization
of chondrogenesis of mesenchymal stem cells with levels of
mRNAs encoding chondrogenic markers as output [19].
Another example was optimizing Drosophila organ culture
conditions employing a mixture design on undifferentiated
cells as organ proxy [20]. However, to our knowledge, this
is the first study combining Fiji-facilitated automatic count-
ing of cells with factorial design to achieve a much higher
throughput. In general, visual inspection of morphology con-
firmed cell viability measurements, while measurement of
dead cells gave conflicting results, possibly due to detach-
ment/lysis of dead cells, thereby making them undetectable.
Regression analysis of results from two different factorial
design experimental setups predicted that glycerol increases
survival of stored CES. Results were consistent across three
out of four experiments using these experimental setups
using two different storage media formulations. The addi-
tives fenoldopam mesylate and possibly L-ascorbic acid
enhanced the effect of glycerol. Though the predicted optimal
concentration of glycerol varied between experiments, possi-
bly due to the use of cells from different donors, the models
indicated a consistent positive effect. We attribute the lack
of effect of glycerol in experiment 2 to the short storage time
(7 days) and the use of cells from an early passage (p2). Cells
may not have been stressed enough to get observable results.
This conclusion is supported by experiment 4, in which
glycerol clearly had a beneficial effect on viability of cells
from a later passage from the same donor during a longer
11-day storage period.
Glycerol has been shown to enter cells via aquaglyceropo-
rins, a subclass of aquaporins including AQP3 which is abun-
dant and important in epidermal cells [21, 22]. Although
glycerol has been widely used as a cryoprotectant, its use in
preserving the essential qualities of cultured cell sheets at
above freezing temperatures pretransplantation has not been
explored. It has been reported that pig skin allografts can be
successfully preserved with 85% glycerol when kept at 4°C
[23, 24]. Studies have shown that a lower concentration of
glycerol (<6% in cell culture or intratesticular injection of a
10% glycerol solution) suppresses proliferation [25, 26].
Wiebe and Dinsdale conducted experiments using several
cell lines and showed that glycerol completely suppressed
proliferation when used at a concentration of 4%–8%
(depending on cell type) [27]. Furthermore, replacement of
glycerol medium with glycerol-free medium resulted in full
recovery of proliferation rate following exposure to 4% glyc-
erol but only partial recovery (65%) following exposure to
10–12% glycerol. Thus, glycerol may shut down important
energy demanding cellular processes, thereby also reducing
oxidative damage and promoting cell survival.
Fenoldopam mesylate is a dopamine 1 receptor (D1R)
agonist shown to stimulate robust activation of AMP-
activated protein kinase (AMPK) in various cell types
[28, 29]. Silencing of AMPK results in reduced mitochon-
drial and eNOS (endothelial NO synthase) content,
reduced cell proliferation, increased accumulation of
ROS, and apoptosis [30]. As shown for fenoldopam mesy-
late, L-ascorbic acid has a well-documented effect on
50 휇m50 휇m 50 휇m
Before storage After storage, highest morphology score After storage, lowest morphology score
Figure 2: Typical light microscopy images illustrating morphology of cells before and after storage for 11 days. The cells were primary
epidermal cells stored at passage 4.
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reduction of oxidative damage to cells [31, 32]. Further-
more, L-ascorbic acid has been shown to have a positive
effect on proliferation of porcine corneal endothelial cells
[33]. We therefore cannot exclude that the beneficial effect
of L-ascorbic acid on increasing the number of viable cells
was due to proliferation during storage.
The optimal predicted concentration of glycerol and the
other recommended additives indicated by Design-Expert©
remain to be tested. Future planned studies include testing
these recommendations with a large number of donors and
using a larger CES area. This experimental setup was consid-
ered too large for inclusion in the present initial work. The
results indicate a positive effect of glycerol on cell viability
in cells from three different donors and two different basic
storage media. Consistent results showing a positive effect
of glycerol across three experiments suggest that using a
multifactorial design may be an innovative and reliable
method to discover the effect of new formulations in
similar setups with various goals and using different cell
types. Furthermore, use of a robot for mixing storage
media and automated cell counting ensured less variation
due to human handling.
5. Conclusions
We have developed a high throughput screening system
enabling robust assessment of live cells and identified
glycerol as a beneficial additive that has a positive effect on
cell survival in CES during storage at 12°C. We believe this
method could be of use in other cell culture optimization
strategies where a large number of groups are compared for
their effect on cell viability or other quantifiable factors.
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